Cardiol Therapeutics Inc.
Price Action
Technical Summary
EMERGING TRENDCardiol Therapeutics Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings growth of 0% provides fundamental context to the price action. Investors should exercise caution due to high volatility (68% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.08 | -4.43% | BELOW |
| 50 SMA | $1.24 | -17.16% | BELOW |
| 100 SMA | $1.18 | -12.77% | BELOW |
| 150 SMA | $1.12 | -8.16% | BELOW |
| 200 SMA | $1.11 | -7.34% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CRDL in an uptrend right now?
CRDL has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is CRDL overbought or oversold?
CRDL's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.
Is CRDL outperforming the market?
CRDL has a Relative Strength (RS) Rating of 34 out of 99. CRDL is currently lagging the broader market.
Where is CRDL in its 52-week range?
CRDL is trading at $1.03, which is 60% of its 52-week high ($1.71) and 18% above its 52-week low ($0.88).
How volatile is CRDL?
CRDL has a Beta of 1.22 and 52-week volatility of 68%. It's more volatile than the S&P 500 - expect bigger swings.